SPCC (Sharing Progress in Cancer Care) shared on LinkedIn:
“Are you looking to bridge the gap between clinical evidence and real-world patient expectations in supportive cancer care?
The on-demand recording of our recent symposium at the MASCC/ISOO 2026 Annual Meeting, ‘Improving outcomes in MEC: clinical evidence, trial insights and the patient perspective’, is now available free of charge on OncoCorner.
Chaired by Matti Aapro and Florian Scotté, this session dives into the persistent challenges and unmet needs in managing moderate emetogenic chemotherapy (MEC).
Featuring critical insights from Mario Di Palma on current treatment landscapes, Matti Aapro on trial data for risk assessment, and Eva Schumacher-Wulf on the patient voice, the discussion delivers essential guidance for healthcare professionals, researchers, and patient advocates alike.
Watch the full session on-demand: Improving outcomes in MEC: clinical evidence, trial insights and the patient perspective.”
Other articles about moderate emetogenic chemotherapy on OncoDaily.